Teufelsbauer Harald, Prusa Alexander M, Wolff Klaus, Polterauer Peter, Nanobashvili Josif, Prager Manfred, Hölzenbein Thomas, Thurnher Siegfried, Lammer Johannes, Schemper Michael, Kretschmer Georg, Huk Ihor
Department of Vascular Surgery, University of Vienna-Medical School, Vienna, Austria.
Circulation. 2002 Aug 13;106(7):782-7. doi: 10.1161/01.cir.0000028603.73287.7d.
Although transfemoral endovascular aneurysm management (TEAM) of infrarenal abdominal aortic aneurysms (AAA) is widely performed, open graft replacement is still considered the standard of care. The aim of this study was to investigate whether clear indications for TEAM can be established in patients with significant comorbidities without investigating differences in relative procedure efficacy or durability.
A propensity score-based analysis of 454 consecutive patients treated electively for AAA from January 1995 through December 2000 was performed. Of those 454 patients, 248 received open surgery and 206 received TEAM. In-hospital mortality rates (MRs) were compared. After adjusting for propensity scores, a Cox proportional hazard model (COX) was employed to test the influence of the respective treatment on postoperative 900-day survival estimates (SEs). Several potential preoperative risk factors were used as covariates. The MR of all patients was 3.7%. Explorative analysis demonstrated that patients treated by TEAM presented with significantly more risk factors. In American Society of Anesthesiologists class IV patients, a significant difference in MR was detected (4.7% for TEAM versus 19.2% for open surgery; P<0.02). After adjusting for the propensity to receive TEAM or open surgery, a regression analysis of survival based on COX revealed predictive influences of impaired kidney (P<0.047) or pulmonary function (P<0.001), increased age (P<0.05), and selection of treatment modality (P<0.002) on SE.
TEAM represents a less invasive procedure for AAA therapy in patients with significant preoperative risk factors. Especially in geriatric patients with multiple morbidities, TEAM offers a method of therapy with acceptable MRs and SEs, making active treatment possible in otherwise incurable patients.
尽管肾下腹主动脉瘤(AAA)的经股动脉血管内动脉瘤治疗(TEAM)已广泛开展,但开放移植置换仍被视为标准治疗方法。本研究的目的是探讨在患有严重合并症的患者中能否确立TEAM的明确适应证,而不探究相对手术疗效或耐久性的差异。
对1995年1月至2000年12月期间连续择期接受AAA治疗的454例患者进行了基于倾向评分的分析。在这454例患者中,248例接受了开放手术,206例接受了TEAM。比较了住院死亡率(MRs)。在调整倾向评分后,采用Cox比例风险模型(COX)来测试各自治疗对术后900天生存估计值(SEs)的影响。几个潜在的术前风险因素被用作协变量。所有患者的MR为3.7%。探索性分析表明,接受TEAM治疗的患者存在明显更多的风险因素。在美国麻醉医师协会IV级患者中,检测到MR有显著差异(TEAM为4.7%,开放手术为19.2%;P<0.02)。在调整接受TEAM或开放手术的倾向后,基于COX的生存回归分析显示,肾功能受损(P<0.047)或肺功能受损(P<0.001)、年龄增加(P<0.05)以及治疗方式的选择(P<0.002)对SE有预测影响。
对于具有显著术前风险因素的患者,TEAM是一种侵入性较小的AAA治疗方法。特别是在患有多种疾病的老年患者中,TEAM提供了一种具有可接受的MR和SE的治疗方法,使原本无法治愈的患者能够接受积极治疗。